Harvard Bioscience buy Benchmark Co.
Start price
10.03.23
/
50%
€2.60
Target price
10.03.24
€3.77
Performance (%)
51.54%
End price
11.03.24
€3.94
Summary
This prediction ended on 11.03.24 with a price of €3.94. With a performance of 51.54% the BUY prediction by Benchmark_Co_ was a big success. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Harvard Bioscience | 2.479% | 2.479% | -70.476% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Benchmark_Co_ for this prediction
In the thread Harvard Bioscience diskutieren
Harvard Bioscience, Inc. (NASDAQ: HBIO) had its price target raised by analysts at Benchmark Co. from $3.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for HBIO provided by MarketBeat
In the thread Trading Harvard Bioscience
Die von Benchmark_Co_ gewählte maximale Laufzeit wurde überschritten